Pharmaceutical Control of the
Human Microbiome


Ward Peterson, PhD
Co-founder, President and CEO

Dr. Peterson has 16 years experience in pharma R&D—drug discovery to Phase 3 studies involving multiple targets and therapeutic areas. His previous employment was with Regeneron Pharmaceuticals and Inspire Pharmaceuticals (Research Scientist to Senior VP).

Matthew Redinbo, PhD
Co-founder and Chief Scientific Officer
Dr. Redinbo is the inventor of Symberix's technology licensed from University of North Carolina, Chapel Hill. He has 25 years of experience in biochemistry, structural and chemical biology. Dr. Redinbo is the Kenan Distinguished Professor of Chemistry, Biochemistry, Microbiology and Genomics at UNC, Chapel Hill.